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Definition
Pulmonary embolism (PE) is a potential cardiovascular 
emergency caused by a sudden blockage in a lung artery by a 
blood clot(s) that has(ve) traveled in most cases, from the legs 
or, rarely, other parts of the body (deep vein thrombosis)  
through the bloodstream (embolism) with symptoms and 
signs that may include shortness of breath, rapid 
breathing, rapid heart rate, chest pain particularly upon 
breathing in, coughing up blood, low blood oxygen 
levels, fever, (in severe cases) abnormally low blood pressure, 
passing out, and sudden death, with rare long-term 
complications in survived patients in form of  chronic 
thromboembolic pulmonary hypertension (CTEPH), leading to 
right heart failure.
mayoclinic.org/diseases-conditions/pulmonary-embolism/home/ovc-20234736 en.wikipedia.org/wiki/Pulmonary_embolism
Epidemiology 1
• The exact number of people affected by deep venous 
thrombosis (DVT) and PE isn't known, estimates suggest 
these conditions affect 300,000 to 600,000 people in the 
United States and 430,000 people  in Europe each year 
• Rates are similar in males and females and become more 
common as people get older 
• If left untreated, about 30 percent of patients who have PE 
will die
• Most of those who die do so within the first few hours of 
the event 
• A prompt diagnosis and proper treatment can save lives 
and help prevent the complications of PE.
https://www.nhlbi.nih.gov/health/health-topics/topics/pe
Epidemiology 2
The majority of VTE events is asymptomatic; while some 
cases present with fatal PE.
http://www.wikidoc.org/index.php/Pulmonary_embolism_epidemiology_and_demographics
Epidemiology 3
http://emedicine.medscape.com/article/167981-overview#a5
Epidemiology 4
http://www.nature.com/nrcardio/journal/v7/n10/images/nrcardio.2010.106-f2.jpg
Risk Factors and Etiology 1
http://www.healthline.com/health/pulmonary-embolus#Riskfactors3
• Leg or pelvic vein thromboses (about 90% of 
emboli)
• Cancer
• A family history of embolisms
• Fractures of the leg or hip
• Hypercoagulable states or genetic blood clotting 
disorders, including factor V Leiden, prothrombin 
gene mutation, and elevated levels of homocysteine 
USMLE Step 2 CK` test  
A 42-year-old woman is brought to the emergency department 
4 hours after the onset of severe shortness of breath. She has 
no recent history of trauma, hospital admission, or operations. 
She had an episode of deep venous thrombosis 10 years ago 
that required treatment in the hospital. Her respirations are 
34/min. Pulse oximetry on room air shows an oxygen saturation 
of 65%. A helical CT scan shows a large filling defect in the right 
pulmonary artery. Which of the following hypercoagulability 
disorders is the most likely underlying cause of these findings? 
(A) Antiplatelet antibody syndrome (B) Antithrombin III 
deficiency (C) Factor V Leiden mutation (D) Protein C deficiency 
(E) Protein S deficiency 
usmle-forums.com/usmle-step-2-ck-forum/16583-five-pulmonology-questions-part-2-a.html
Risk Factors and Etiology 2
nejm.org/doi/full/10.1056/NEJMp048088 healthline.com/health/pulmonary-embolus#Riskfactors3
• A history of heart attack or stroke
• Major surgery
• Obesity
• A sedentary lifestyle
• Age over 60 years
• Taking estrogen or testosterone.
A - a whitish-yellow, fibrotic, organized thromboembolus from a patient with chronic 
pulmonary embolism
B - fresh red thrombi that were recovered from a patient with acute pulmonary embolism.
Risk Factors and Etiology 3               
Virchow's Triad
https://en.wikipedia.org/wiki/Pulmonary_embolism#Risk_factors
1. Alterations in blood flow: immobilization (after surgery), 
injury, pregnancy, obesity , cancer
2. Factors in the vessel wall: surgery, catheterizations
3. Factors affecting the properties of the blood: estrogen-
containing hormonal contraception, genetic thrombophilia 
(factor V Leiden, prothrombin mutation G20210A, protein 
C deficiency, protein S 
deficiency, antithrombin deficiency, hyperhomocysteinemi
a and plasminogen/fibrinolysis disorders), acquired 
thrombophilia (antiphospholipid syndrome, nephrotic 
syndrome, paroxysmal nocturnal hemoglobinuria), 
cancer (secretion of pro-coagulants).
Mechanism 1
• Although PE can arise from anywhere in the body, 
most commonly it arises from the calf veins
• The venous thrombi predominately originate in 
venous valve pockets (inset) and at other sites of 
presumed venous stasis
• Acute PE interferes with both the circulation and 
gas exchange
• The manifestations of PE depend upon four main 
factors: 
– a) the extent of occlusion of the vascular tree 
http://emedicine.medscape.com/article/300901-overview
Mechanism 2
–b) the patient’s pre-existing cardiopulmonary 
condition  
– c) chemical vasoconstriction due to the release of 
serotonin and thromboxane from platelets that 
adhere to the embolus, as well as to fibropeptide 
B, which is a product of fibrinogen breakdown 
–d) the reflex vasoconstriction that is likely to 
occur as a consequence of pulmonary artery 
dilatation 
• Right ventricular (RV) failure due to pressure 
overload is the primary cause of death in severe PE. 
http://emedicine.medscape.com/article/300901-overview
Mechanism 3
http://www.pfizerindia.com/enewswebsite/images/image004.jpg
Mechanism 4
http://images.slideplayer.com/6/5661625/slides/slide_37.jpg
Mechanism 5
myheart.net/articles/pulmonary-embolism-the-killer-clot-in-the-lungs/ mayoclinic.org/diseases-conditions/pulmonary-embolism/symptoms-causes/dxc-20234744
A clot being extracted 
surgically from the lung 
artery of a patient with a 
massive pulmonary 
embolism.
Mechanism 6
http://eurheartj.oxfordjournals.org/content/35/43/3033
Key factors contributing to hemodynamic collapse in 
acute PE.
Mechanism 7
Respiratory Consequences
• Increased alveolar dead space
• Hypoxemia
• Hyperventilation
• Regional loss of surfactant and pulmonary infarction
• Arterial hypoxemia, that include ventilation-perfusion 
mismatch, intrapulmonary shunts, reduced cardiac output, 
and intracardiac shunt via a patent foramen ovale
• Pulmonary infarction is an uncommon consequence 
because of the bronchial arterial collateral circulation.
http://emedicine.medscape.com/article/300901-overview#a4
Mechanism 8
Hemodynamic Consequences 1
• PE reduces the cross-sectional area of the pulmonary 
vascular bed, resulting in an increment in pulmonary 
vascular resistance, which, in turn, increases the right 
ventricular afterload
• If the afterload is increased severely, right ventricular 
failure may ensue
• The humoral and reflex mechanisms contribute to the 
pulmonary arterial constriction 
http://emedicine.medscape.com/article/300901-overview#a4
Mechanism 9
Hemodynamic Consequences 2
• Following the initiation of anticoagulant therapy, the 
resolution of emboli usually occurs rapidly during the first 2 
weeks of therapy; however, it can persist on chest imaging 
studies for months to years
• Chronic pulmonary hypertension may occur with failure of 
the initial embolus to undergo lyses or in the setting of 
recurrent thromboemboli.
http://emedicine.medscape.com/article/300901-overview#a4
Classification 
International Classification of Diseases  
http://apps.who.int/classifications/icd10/browse/2016/en#/J45
• IX Diseases of the circulatory system
(I00-I99)
• Pulmonary heart disease and diseases of 
pulmonary circulation
(I26-I28)
• 126 Pulmonary embolism
• 126.0 Pulmonary embolism with mention 
of acute cor pulmonale
• 126.9 Pulmonary embolism without 
mention of acute cor pulmonale.
Classification 
Risk Groups
http://eurheartj.oxfordjournals.org/content/35/43/3033 ifeinthefastlane.com/pulmonary-embolus-pondering/
• High risk (previously ‘massive’) PE 
patients have persistent shock or 
hypotension 
• Intermediate risk (previously ‘sub-
massive’) PE is defined as the 
presence of right ventricular (RV) 
dysfunction and/or myocardial 
injury in the absence of 
hypotension 
• Low risk PE patients have none of 
these features and can probably 
be treated outside of hospital.
Symptoms and Signs
Symptoms of pulmonary embolism are typically sudden in 
onset and may include one or many of the following:
• Dyspnea (shortness of breath)
• Tachypnea (rapid breathing)
• Chest pain of a "pleuritic" nature (worsened by breathing) 
• Cough
• Hemoptysis (coughing up blood)
• Cyanosis (blue discoloration, usually of the lips and fingers)
• Collapse
• Circulatory instability because of decreased blood flow 
through the lungs and into the left side of the heart.  
https://en.wikipedia.org/wiki/Pulmonary_embolism#Signs_and_symptoms
History 1
• Most DVTs start in the calf, and most probably 
resolve spontaneously
• Thrombi that remain confined to the calf rarely 
cause leg symptoms or symptomatic PE
• The probability that calf DVT will extend to involve 
the proximal veins and subsequently cause PE 
increases with the severity of the initiating 
prothrombotic stimulus 
http://circ.ahajournals.org/content/107/23_suppl_1/I-22
History 2
• Although acute VTE usually presents with either leg 
or pulmonary symptoms, most patients have 
thrombosis at both sites at the time of diagnosis
• Proximal DVTs resolve slowly during treatment with 
anticoagulants, and thrombi remain detectable in 
half of the patients after a year
• Resolution of DVT is less likely in patients with a 
large initial thrombus or cancer
http://circ.ahajournals.org/content/107/23_suppl_1/I-22
History 3
• 10% of patients with symptomatic DVTs develop 
severe post-thrombotic syndrome within 5 years
• 10% of PEs are rapidly fatal, and an additional 5% 
cause death later, despite diagnosis and treatment
• 50% of diagnosed PEs are associated with right 
ventricular dysfunction, which is associated with a 
≈5-fold greater in-hospital mortality 
http://circ.ahajournals.org/content/107/23_suppl_1/I-22
History 4
• There is ≈50% resolution of PE after 1 month of 
treatment, and perfusion eventually returns to 
normal in two thirds of patients
• 5% of treated patients with PE develop pulmonary 
hypertension as a result of poor resolution
• After a course of treatment, the risk of recurrent 
thrombosis is higher in patients without reversible 
risk factors.
http://circ.ahajournals.org/content/107/23_suppl_1/I-22
Physical Examination 1
• The lungs are usually normal
• Occasionally, a pleural friction rub may be audible 
over the affected area of the lung (mostly in PE 
with infarct)
• A pleural effusion is sometimes present that is 
exudative, detectable by decreased percussion 
note, audible breath sounds, and vocal resonance 
http://emedicine.medscape.com/article/167981-clinical#b2
Physical Examination 2
• Strain on the right ventricle may be detected as a 
left parasternal heave, a loud pulmonary 
component of the second heart sound, and/or 
raised jugular venous pressure
• A low-grade fever may be present, particularly if 
there is associated pulmonary hemorrhage or 
infarction  
• The chest X-ray is frequently abnormal and, 
although its findings are usually non-specific in PE
http://emedicine.medscape.com/article/167981-clinical#b2
Physical Examination 3
• As smaller PE tend to lodge in more peripheral 
areas without collateral circulation they are more 
likely to cause lung infarction and small effusions 
(both of which are painful), but not hypoxia, 
dyspnea or hemodynamic instability such as 
tachycardia
• Larger PEs, which tend to lodge centrally, typically 
cause dyspnea, hypoxia, low blood pressure, fast 
heart rate and fainting, but are often painless 
because there is no lung infarction due to collateral 
circulation 
http://emedicine.medscape.com/article/167981-clinical#b2
Physical Examination 4
• The classic presentation for PE with pleuritic pain, 
dyspnea and tachycardia is likely caused by a large 
fragmented embolism causing both large and small 
PEs
• Small PEs are often missed because they cause 
pleuritic pain alone without any other findings and 
large PEs often missed because they are painless 
and mimic other conditions .
http://emedicine.medscape.com/article/167981-clinical#b2
Physical Examination 5
Massive Pulmonary Embolism
• Patients with massive pulmonary embolism are in shock 
and have systemic hypotension, poor perfusion of the 
extremities, tachycardia, and tachypnea
• In addition, patients appear weak, pale, sweaty, and 
oliguric and develop impaired mentation
• Massive pulmonary embolism has been defined by 
hemodynamic parameters and evidence of myocardial 
injury rather than anatomic findings because the former is 
associated with adverse outcomes 
• Anatomic findings by computer tomography (CT) scan may 
be important in assessing risk in hemodynamically stable 
patients with pulmonary embolus. http://emedicine.medscape.com/article/300901-clinical#showall
Physical Examination  6
Acute Pulmonary Infarction
• Approximately 10% of patients have peripheral occlusion of 
a pulmonary artery, causing parenchymal infarction
• These patients present with acute onset of pleuritic chest 
pain, breathlessness, and hemoptysis
• Although the chest pain may be clinically indistinguishable 
from ischemic myocardial pain, normal electrocardiography  
findings and no response to nitroglycerin rules out 
myocardial pain
• Patients with acute pulmonary infarction have decreased 
excursion of the involved hemithorax, palpable or audible 
pleural friction rub, and even localized tenderness
• Signs of pleural effusion may be present.
http://emedicine.medscape.com/article/300901-clinical#showall
Physical Examination 7
Acute Embolism without Infarction
• Patients with acute embolism without infarction have 
nonspecific physical signs that may easily be secondary to 
another disease process
• Tachypnea and tachycardia frequently are detected, 
pleuritic pain sometimes may be present, crackles may be 
heard in the area of embolization, and local wheeze may be 
heard rarely.
http://emedicine.medscape.com/article/300901-clinical#showall
Physical Examination  8
Multiple Pulmonary Emboli or Thrombi
• Patients with pulmonary emboli and thrombi have physical 
signs of pulmonary hypertension and cor pulmonale
• Patients may have elevated jugular venous pressure, right 
ventricular heave, palpable impulse in the left second 
intercostal space, right ventricular S3 gallop, systolic 
murmur over the left sternal border that is louder during 
inspiration, hepatomegaly, ascites, and dependent pitting 
edema
• These findings are not specific for pulmonary embolism 
and require a high index of suspicion for pursuing 
appropriate diagnostic studies.
http://emedicine.medscape.com/article/300901-clinical#showall
Complications
http://www.webmd.com/lung/tc/pulmonary-embolism-what-happens
• Cardiac arrest and sudden death
• Shock
• Abnormal heart rhythms
• Pulmonary infarction
• Pleural effusion 
• Paradoxical embolism
• Pulmonary hypertension.
USMLE Step 2 CK` test  
A 67-year-old woman comes to the physician for a follow-up examination. She 
had a pulmonary embolism and required treatment in the hospital for 3 weeks. 
She had a retroperitoneal hemorrhage; anticoagulant therapy was temporarily 
discontinued, and she underwent placement of an inferior vena cava (IVC) 
filter. She had a hematoma that was resolving on discharge from the hospital 2 
weeks ago. Today, she says she has had a persistent sensation of tingling and 
numbness of her left thigh that she did not report in the hospital because she 
thought it would go away; the sensation has improved somewhat during the 
past week. Her only medication is warfarin. Vital signs are within normal limits. 
Examination of the skin shows no abnormalities. Muscle strength is normal. 
Sensation to light touch is decreased over a 5 x 5-cm area on the lateral aspect 
of the left anterior thigh. Which of the following is the most likely cause of this 
patient's decreased sensation? 
(A) Cerebral infarction during the hospitalization (B) Complication of the IVC 
filter placement (C) Compression of the lateral femoral cutaneous nerve (D) 
Hematoma of the left thigh (E) Spinal cord infarct (F) Vitamin B12 (cobalamin) 
deficiency. usmle-forums.com/usmle-step-2-ck-forum/16583-five-pulmonology-questions-part-2-a.html
Diagnosis 1                                           
Clinical Presentation 1
• PE may escape prompt diagnosis since the clinical 
signs and symptoms are non-specific 
• When the clinical presentation raises the suspicion 
of PE in an individual patient, it should prompt 
further objective testing
• In most patients, PE is suspected on the basis of 
dyspnea, chest pain, pre-syncope or syncope, 
and/or hemoptysis
• Knowledge of the predisposing factors for VTE is 
important in determining the likelihood of PE 
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 2                                           
Clinical Presentation 2
• In blood gas analysis, hypoxemia is considered a 
typical finding in acute PE, but up to 40% of the 
patients have normal arterial oxygen saturation and 
20% a normal alveolar-arterial oxygen gradient
• Electrocardiographic changes indicative of RV strain, 
and incomplete or complete right bundle-branch 
block, may be helpful ; atrial arrhythmias, may be 
associated with acute PE.
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 3                                          
Electrocardiographic Changes 
Sinus tachycardia, simultaneous T-wave inversions in the 
anterior (V1-4) and inferior leads (II, III, aVF), non-specific ST 
changes – slight ST elevation in III and aVF.
http://lifeinthefastlane.com/ecg-library/pulmonary-embolism/
Diagnosis 4                                           
Assessment Of Clinical Probability
• Despite the limited sensitivity and specificity of individual 
symptoms, signs, and common tests, the combination of 
findings evaluated by clinical judgement or by the use of 
prediction rules allows to classify patients with suspected 
PE into distinct categories of clinical or pre-test probability 
that correspond to an increasing actual prevalence of 
confirmed PE
• As the post-test (e.g. after computed tomography) 
probability of PE depends not only on the characteristics of 
the diagnostic test itself but also on pre-test probability, 
this has become a key step in all diagnostic algorithms for 
PE.
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 5                                           
Clinical Probability Scoring: The Wells’ Score 
http://img.medscape.com/fullsize/migrated/575/056/path575056.tab1.gif
Diagnosis 6   
D-dimer Testing
• D-dimer levels are elevated in plasma in the presence of 
acute thrombosis because of simultaneous activation of 
coagulation and fibrinolysis
• The negative predictive value of D-dimer testing is high and 
a normal D-dimer level renders acute PE or DVT unlikely
• On the other hand, fibrin is also produced in a wide variety 
of conditions such as cancer, inflammation, bleeding, 
trauma, surgery and necrosis
• Accordingly, the positive predictive value of elevated D-
dimer levels is low and D-dimer testing is not useful for 
confirmation of PE. 
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 7  
Computed Tomographic Pulmonary Angiography
• Since the introduction of multi-detector computed 
tomographic (MDCT) angiography with high spatial and 
temporal resolution and quality of arterial opacification, CT 
angiography has become the method of choice for imaging 
the pulmonary vasculature in patients with suspected PE
• It allows adequate visualization of the pulmonary arteries 
down to at least the segmental level.
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 8                                      
Multi-detector Computed Tomographic Angiography
Pulmonary emboli in the middle and in the anterior branches 
of the left lung (arrow), and several lung nodules in both 
lungs.
https://www.researchgate.net/figure/42343864_fig5_Figure-6-Pulmonary-computed-tomography-angiography-images-demonstrated-pulmonary-emboli
Diagnosis 9   
Lung Scintigraphy
• Ventilation–perfusion scintigraphy (V/Q scan) is an 
established diagnostic test for suspected PE
• V/Q scan is safe and few allergic reactions have been 
described
• The test is based on the intravenous injection of 
technetium (Tc)-99m-labelled macroaggregated albumin 
particles, which block a small fraction of the pulmonary 
capillaries and thereby enable scintigraphic assessment of 
lung perfusion
• Perfusion scans are combined with ventilation studies, for 
which multiple tracers such as xenon-133 gas, Tc-99m-
labelled aerosols can be used 
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 10                                       
Ventilation–perfusion Scintigraphy 
An abnormal nuclear lung scan shows areas without nuclear 
particles (arrows). This finding indicates that pulmonary 
emboli (blood clots) may be present. A normal lung scan is 
shown on the right for comparison.
http://web.carteret.edu/keoughp/LFreshwater/CPAP/V-Q%20Relationships/VQClassNotes.htm
Diagnosis 11  
Pulmonary Angiography 1
• Pulmonary angiography has for decades remained 
the ‘gold standard' for the diagnosis or exclusion of 
PE, but is rarely performed now as less-invasive CT 
angiography offers similar diagnostic accuracy
• The diagnosis of acute PE is based on direct 
evidence of a thrombus in two projections, either as 
a filling defect or as amputation of a pulmonary 
arterial branch 
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 12 
Pulmonary Angiography 2
• Thrombi as small as 1–2 mm within the sub-
segmental arteries can be visualized , but there is 
substantial inter-observer variability at this level
• Indirect signs of PE, such as slow flow of contrast, 
regional hypoperfusion, and delayed or diminished 
pulmonary venous flow, are not validated and 
hence are not diagnostic.  
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 13                                       
Pulmonary angiography as the ‘gold standard' for the 
diagnosis or exclusion of PE
Organized thrombi appear as unusual filling defects, 
webs, or bands, or completely thrombosed vessels 
that may resemble congenital absence of the vessel.
http://web.carteret.edu/keoughp/LFreshwater/CPAP/V-Q%20Relationships/VQClassNotes.htm
Diagnosis 14   
Magnetic Resonance Angiography
• Magnetic resonance angiography (MRA) has been 
evaluated for several years in suspected PE but large-scale 
studies were published only recently
• Their results show that this technique, although promising, 
is not yet ready for clinical practice due to its low 
sensitivity, high proportion of inconclusive MRA scans, and 
low availability in most emergency settings .
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 15 
Echocardiography
• Acute PE may lead to right ventricle (RV) pressure overload and 
dysfunction, which can be detected by echocardiography 
• Given the peculiar geometry of the RV, there is no individual 
echocardiographic parameter that provides fast and reliable 
information on RV size or function
• Signs of RV overload or dysfunction may also be found in the absence 
of acute PE and be due to concomitant cardiac or respiratory disease.
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 16
Echocardiography Signs
A patient with acute pulmonary thromboembolism. In the 
diastole, the ratio of the right ventricular end-diastolic area 
to left ventricular end-diastolic area was more than 1.0 which 
is consistent with severe right ventricular dysfunction (normal 
value is less than 0.6).
https://synapse.koreamed.org/DOIx.php?id=10.4250/jcu.2008.16.1.9&vmode=PUBREADER
Diagnosis 17
Validated Diagnostic Criteria
http://eurheartj.oxfordjournals.org/content/35/43/3033
Diagnosis 18 
Differentiation 1
• Acute Coronary Syndrome
• Acute Pericarditis
• Acute Respiratory Distress 
Syndrome
• Angina Pectoris
• Anxiety Disorders
• Aortic Stenosis
• Atrial Fibrillation
• Cardiogenic Shock
• Cor Pulmonale
• Dilated Cardiomyopathy
• Emphysema
• Fat Embolism
http://emedicine.medscape.com/article/300901-differential
Diagnosis 19 
Differentiation 2
• Hypersensitivity Pneumonitis
• Mitral Stenosis
• Myocardial Infarction
• Pneumothorax Imaging
• Pulmonary Arterial 
Hypertension
• Pulmonary Arteriovenous 
Fistulae
• Restrictive 
Cardiomyopathy 
• Sudden Cardiac Death
• Superior Vena Cava 
Syndrome in Emergency 
Medicine
• Syncope
http://emedicine.medscape.com/article/300901-differential
Management 1  
• Anticoagulant therapy is the mainstay of treatment
• Acutely, supportive treatments, such 
as oxygen or analgesia, may be required
• People are often admitted to hospital in the early 
stages of treatment, and tend to remain under 
inpatient care until the international normalized 
ratio (INR) has reached therapeutic levels
• Low-risk cases are managed at home in a fashion 
already common in the treatment of DVT
• Evidence to support one approach versus the other 
is weak.
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
Management  2                                  
Anticoagulation 1 
• Anticoagulant therapy is the mainstay of treatment 
(heparin, low molecular weight heparin (LMWH), 
fondaparinux, warfarin, acenocoumarol, 
or phenprocoumon)
• LMWH may reduce bleeding among people with 
pulmonary embolism as compared to heparin 
• Warfarin therapy often requires a frequent dose 
adjustment and monitoring of the INR: INRs 
between 2.0 and 3.0 are generally considered ideal 
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
Management  3                                  
Anticoagulation 2 
• In patients with an underlying malignancy, therapy 
with a course of LMWH is favored over warfarin 
• Similarly, pregnant women are often maintained on 
low molecular weight heparin until at least six 
weeks after delivery to avoid the known 
teratogenic effects of warfarin, especially in the 
early stages of pregnancy. 
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
USMLE Step 2 CK` test  
A 65-year-old woman who recently underwent hip 
replacement comes to the emergency department with 
the acute onset of shortness of breath and tachycardia. 
The chest x-ray is normal, with hypoxia on ABG, an 
increased A-a gradient, and an EKG with sinus 
tachycardia. 
What is the most appropriate next step in management? 
A. Intravenous unfractionated heparin, B. Thrombolytics 
Inferior vena cava filter, C. Embolectomy, D. Spiral CT 
scan, E. Ventilation/perfusion (V/Q) scan, F. Lower-
extremity, G. Doppler studies, H. 0-dimer
usmle-forums.com/usmle-step-2-ck-forum/16583-five-pulmonology-questions-part-2-a.html
Management  4                                  
Thrombolysis
• Massive PE causing hemodynamic instability is an indication 
for thrombolysis, the enzymatic destruction of the clot with 
medication
• Catheter-directed thrombolysis (CDT) is a new technique 
found to be relatively safe and effective for massive Pes
• Medication that breaks up blood clots is released through 
the catheter so that its highest concentration is directly next 
to the pulmonary embolus
• CDT is performed by interventional radiologists, and in 
medical centers that offer CDT, it should be considered first-
line treatment 
• The use of thrombolysis in non-massive PEs is still debated. 
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
Management   5                                  
Inferior Vena Cava Filter 1
• There are two situations when an inferior vena cava 
filter is considered advantageous, and those are if 
anticoagulant therapy is contraindicated (e.g. 
shortly after a major operation), or a person has a 
pulmonary embolus in spite of being anticoagulated 
• In these instances, it may be implanted to prevent 
new or existing DVTs from entering the pulmonary 
artery and combining with an existing blockage  
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
Management  6                                   
Inferior Vena Cava Filter 2
• Inferior vena cava filters should be removed as soon 
as it becomes safe to start using anticoagulation.
• Although modern filters are meant to be retrievable, 
complications may prevent some from being 
removed
• The long-term safety profile of permanently leaving 
a filter inside the body is not known.
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
USMLE Step 2 CK` test  
A 29-year-old man comes to the emergency department because of the acute 
onset of dyspnea and pleuritic chest pain for the last 2 hours. He has a known 
history of Factor V Leiden deficiency. His condition was discovered 4 months 
prior, when he suffered a pulmonary embolus and was placed on warfarin. 
Aside from this condition and its complications, his past medical history is 
unremarkable. Currently his vital signs are: temperature 37.0 C, blood pressure 
150/95 mm Hg, pulse 112/min, respirations 30/min, and oxygen saturation 
97%. Chest examination reveals some diffuse crackles at the right base. A CT-
angiogram shows two small filling defects in the right lower lobe pulmonary 
vasculature. STAT (urgent) coagulation laboratory studies reveal an INR of 3.2 
and an activated Partial Thromboplastin Time (aPPT)of 28 seconds. In addition 
to starting heparin, which of the following is an appropriate management for 
this patient?
A. Add aminocaproic acid, B. Begin thrombolytic therapy, C. Increase the dose 
of warfarin, D. Send him for a thrombectomy, E. Surgically place an inferior 
vena cava filter
usmle-forums.com/usmle-step-2-ck-forum/16583-five-pulmonology-questions-part-2-a.html
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Surgery
• Surgical management of acute PE (pulmonary 
thrombectomy) is uncommon and has largely been 
abandoned because of poor long-term outcomes
• However, recently, it has gone through a resurgence with 
the revision of the surgical technique and is thought to 
benefit certain people
• Chronic PE leading to pulmonary hypertension (known 
as chronic thromboembolic hypertension) is treated with a 
surgical procedure known as a pulmonary 
thromboendarterectomy.
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
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Suspected PE wit shock or hypotension
https://www.thrombosisadviser.com/pulmonary-embolism-diagnosis/
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Suspected PE without shock or hypotension
https://www.thrombosisadviser.com/pulmonary-embolism-diagnosis/
Prognosis
• Less than 5 to 10% of symptomatic PEs are fatal 
within the first hour of symptoms 
• Prognosis depends on the amount of lung that is 
affected and on the co-existence of other medical 
conditions; chronic embolization to the lung can 
lead to pulmonary hypertension
• Once anticoagulation is stopped, the risk of a fatal 
pulmonary embolism is 0.5% per year 
• Mortality from untreated PEs was said to be 26%.  
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
Prophylaxis
• PE may be preventable in those with risk factors
• People admitted to hospital may receive 
preventative medication, including 
unfractionated heparin, low molecular weight 
heparin, or fondaparinux, and anti-thrombosis 
stockings to reduce the risk of a DVT in the leg that 
could dislodge and migrate to the lungs 
• Following the completion of warfarin in those with 
prior PE, long-term aspirin is useful to prevent 
recurrence.
https://en.wikipedia.org/wiki/Pulmonary_embolism#Diagnosis
Abbreviations 
aPPT - activated partial thromboplastin time 
DVT - deep venous thrombosis 
CDT - catheter-directed thrombolysis 
CT - computed tomography 
CTEPH - chronic thromboembolic pulmonary hypertension 
INR - international normalized ratio 
LMWH - low molecular weight heparin
MDCT - multi-detector computed tomography
MRA - magnetic resonance angiography 
PE - pulmonary embolism
RV - right ventricle 
VTE - venous thromboembolism
V/Q scan - ventilation–perfusion scintigraphy
Diagnostic and treatment guidelines
Acute pulmonary embolism
2014 ESC Guidelines on the diagnosis and management of acute 
pulmonary embolism
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Pulmonary Embolism Treatment & Management
Management of Massive and Submassive Pulmonary Embolism, 
Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic 
Pulmonary Hypertension
Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best 
Practice Advice From the Clinical Guidelines Committee of the American 
College of Physicians
